Outcome of symptomatic intracranial atherosclerotic disease.


BACKGROUND AND PURPOSE Patients with intracranial atherosclerotic disease have a 3.6% to 22% annual risk of stroke. In this study, we sought to evaluate the natural history and prognosis of patients with symptomatic intracranial atherosclerotic disease who received medical therapy versus percutaneous transluminal angioplasty and stenting (PTAS) at our… (More)
DOI: 10.1161/STROKEAHA.109.549972


5 Figures and Tables